MIRA PHARMACEUTICALS, INC. (MIRA)
About MIRA PHARMACEUTICALS, INC.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$10.4M
- Total assets
- $11.1M
- Market cap
- $42.0M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Operating expenses
- $10.5M
- Net income
- -$10.4M
- EPS (basic)
- $-1.35
- EPS (diluted)
- $-1.35
Balance sheet
- Total assets
- $11.1M
- Current assets
- $11.1M
- Total liabilities
- $702.1K
- Current liabilities
- $702.1K
- Shareholders’ equity
- $10.4M
Cash flow
- Operating cash flow
- -$4.7M
- Investing cash flow
- -$3.5M
- Financing cash flow
- $8.2M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $42.0M
- EPS (diluted)
- $-1.35
- Shares outstanding
- 47.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 3, 2023
Mira Pharmaceuticals, Inc. (MIRA) Stock Price
- Reported a net loss of $10.4M.
- Trading 56% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review MIRA PHARMACEUTICALS, INC..
Write a review
News about MIRA PHARMACEUTICALS, INC.
News & sentiment via Polygon.io
Mira Pharmaceuticals, Inc.: frequently asked questions
Is Mira Pharmaceuticals, Inc. an American company?
Mira Pharmaceuticals, Inc. is a US-based company headquartered in Miami, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Mira Pharmaceuticals, Inc. headquartered?
Mira Pharmaceuticals, Inc. is headquartered in Miami, Florida, United States.
Is Mira Pharmaceuticals, Inc. publicly traded?
Yes — Mira Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol MIRA on the NASDAQ.
What does Mira Pharmaceuticals, Inc. do?
Mira Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
